Sheridan Capital Partners has invested in RS&A, a medical device service provider.
RS&A specializes in many support services needed to maintain radiotherapy devices used to treat cancer patients.
“The entire RS&A leadership team and I are excited for the next chapter of growth in partnership with Sheridan,” said DJ Conrad, CEO of RS&A. “Sheridan’s investment and healthcare expertise will amplify our ability to deliver responsive, professional, and high-quality services to our valued clients and help improve patient care.”
McGuire Woods LLP served as legal counsel to Sheridan Capital Partners. Kroll served as financial advisor to RS&A.